Australija - anglų - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - ritonavir -

Airija - anglų - HPRA (Health Products Regulatory Authority)

abbvie limited - foslevodopa; foscarbidopa - solution for infusion - dopa and dopa derivatives

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - botulinum toxin type a 50 u - powder for injection - 50 u - active: botulinum toxin type a 50 u excipient: albumin sodium chloride - · for the prophylaxis of headaches in adults with chronic migraine (headaches on at least 15 days per month with headache lasting 4 hours a day or longer, of which at least 8 days are with migraine)

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - botulinum toxin type a 100 u - powder for injection - 100 u - active: botulinum toxin type a 100 u excipient: albumin sodium chloride - botox® (botulinum toxin type a) purified neurotoxin complex is indicated: · for the prophylaxis of headaches in adults with chronic migraine (headaches on at least 15 days per month with headache lasting 4 hours a day or longer, of which at least 8 days are with migraine)

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - botulinum toxin type a 200 u - powder for injection - 200 u - active: botulinum toxin type a 200 u excipient: albumin sodium chloride - · the treatment of urinary incontinence due to neurogenic detrusor overactivity (eg. spinal cord injury or multiple sclerosis) in adults who have an inadequate response to or are intolerant of an anticholinergic medication.

Airija - anglų - HPRA (Health Products Regulatory Authority)

abbvie limited - levodopa; carbidopa - intestinal gel - 20/5 milligram(s)/millilitre - dopa and dopa derivatives; levodopa and decarboxylase inhibitor

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - carbidopa monohydrate 5 mg/ml;  ; levodopa 20 mg/ml;   - intestinal gel - 20 mg/ml, 5 mg/ml - active: carbidopa monohydrate 5 mg/ml   levodopa 20 mg/ml   excipient: carmellose sodium purified water - treatment of advanced idiopathic parkinson's disease with severe motor fluctuations despite optimised alternative pharmacological treatment.

Airija - anglų - HPRA (Health Products Regulatory Authority)

abbvie limited - botulinum toxin type a - powder for solution for injection - other muscle relaxants, peripherally acting agents; botulinum toxin

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - isoflurane 100% - volatile liquid for inhalation - 100 % - active: isoflurane 100%

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

abbvie limited - leuprorelin acetate 5 mg/ml - solution for injection - 5 mg/ml - active: leuprorelin acetate 5 mg/ml excipient: benzyl alcohol glacial acetic acid sodium chloride sodium hydroxide water for injection - lucrin (leuprorelin acetate) is indicated · in metastatic prostate cancer · in locally advanced prostate cancer, as an alternative to surgical castration · as an adjuvant treatment to radiotherapy in patients with high-risk localized or locally advanced prostate cancer · as an adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression